Back in 2004, a popular arthritis drug called Vioxx was pulled off the market when studies showed daily long-term use could increase the risk of heart attack, stroke and death. “This was one of the ...
NEW YORK (Reuters) - Ads for Pfizer Inc.'s Celebrex arthritis drug are set to splash across U.S. television screens on Monday after more than a two-year hiatus, with an unusual upfront focus on its ...
An FDA panel found Celebrex does not cause a greater risk of heart attacks and strokes compared to two other commonly prescribed painkillers, NPR reports. Here are five things to know. 1. Celecoxib is ...
NEW ORLEANS — A new study gives some reassurance to arthritis sufferers who want pain relief but are worried about side effects. It finds that Celebrex, a drug similar to ones withdrawn 12 years ago ...
It’s been a painful 15 months both for people with arthritis and for the companies that make their painkilling drugs. The once high-flying anti-inflammatories known as cox-2 inhibitors nearly crashed ...
Celebrex, a commonly used painkiller and treatment for arthritis, doubles the risk of a heart attack, researchers said on Wednesday. Professor Richard Beasley, of New Zealand’s Medical Research ...
TORONTO, Dec. 11, 2018 /CNW/ - Delivra Corp. (TSXV: DVA - "Delivra" or the "Company") today announced the publication of positive data from a pre-clinical study demonstrating the safety and efficacy ...
Pfizer is on the hot seat after a consumer group accused the pharmaceutical giant of playing down the safety risks of Celebrex in a new spot. The world's biggest drugmaker began running TV ads for ...
Can a common anti-inflammatory drug help prevent lung cancer? Researchers at UCLA’s Jonsson Cancer Center are seeking volunteers for two new research studies to find out. For the first time, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results